Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: Madharry who wrote (665)	12/8/2001 11:30:57 AM
From: tuck	Read Replies (1) \| Respond to of 1127

I'm speaking mostly technically here. As Steve points out in the previous post, there isn't likely to be any clinical news for a while. siliconinvestor.com Seems to me HGSI is about to fill a little gap from early mid-October. It will probably overshoot that (especially in the context of a market correction). The stochs seem to be on their second down leg before doing a bullish crossover, and RSI is oversold, too. I think a double bottom or perhaps a somewhat higher low than the bottom, is coming. That the buying op for seasonal/technical purposes is in the low 30s - high 20s. (OT -- still watching UCOMA, almost bought in pennies. But when InfoStream shows up to dis your stock, it's a good idea to listen. He's sharp, and he's easier to get along with than many apparent perma-bears. Will any of these debt laden networks come out of it OK in the end? It's an interesting thing to watch.) Cheers, Tuck